Parkman Healthcare Partners’s Axogen AXGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.32M | Buy |
674,551
+137,719
| +26% | +$1.49M | 0.84% | 45 |
|
|
2025
Q1 | $9.93M | Buy |
536,832
+171,129
| +47% | +$3.17M | 1.18% | 30 |
|
|
2024
Q4 | $6.03M | Sell |
365,703
-47,185
| -11% | -$778K | 0.8% | 42 |
|
|
2024
Q3 | $5.79M | Buy |
+412,888
| New | +$5.79M | 0.74% | 47 |
|
|
2023
Q3 | – | Sell |
-260,858
| Closed | -$2.38M | – | 103 |
|
|
2023
Q2 | $2.38M | Buy |
260,858
+37,075
| +17% | +$338K | 0.41% | 69 |
|
|
2023
Q1 | $2.11M | Buy |
223,783
+33,728
| +18% | +$319K | 0.46% | 56 |
|
|
2022
Q4 | $1.9M | Sell |
190,055
-9,945
| -5% | -$99.3K | 0.51% | 58 |
|
|
2022
Q3 | $2.38M | Buy |
200,000
+11,506
| +6% | +$137K | 0.68% | 52 |
|
|
2022
Q2 | $1.54M | Buy |
188,494
+59,547
| +46% | +$488K | 0.57% | 48 |
|
|
2022
Q1 | $1.02M | Sell |
128,947
-77,651
| -38% | -$617K | 0.3% | 67 |
|
|
2021
Q4 | $1.94M | Buy |
206,598
+6,598
| +3% | +$61.8K | 0.43% | 59 |
|
|
2021
Q3 | $3.16M | Sell |
200,000
-37,652
| -16% | -$595K | 0.8% | 37 |
|
|
2021
Q2 | $5.14M | Buy |
237,652
+26,053
| +12% | +$563K | 1.12% | 34 |
|
|
2021
Q1 | $4.29M | Sell |
211,599
-18,910
| -8% | -$383K | 1% | 33 |
|
|
2020
Q4 | $4.13M | Buy |
230,509
+105,509
| +84% | +$1.89M | 1.06% | 39 |
|
|
2020
Q3 | $1.45M | Buy |
+125,000
| New | +$1.45M | 0.39% | 66 |
|